Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence (Q39367756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Koichi Ito

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

7 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

561-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

Metastasis: from dissemination to organ-specific colonization

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Molecular basis of metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Immune escape as a fundamental trait of cancer: focus on IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1 as a potential cancer target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Role of Stat3 in suppressing anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Regulatory T cells and breast cancer: implications for immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Tumor-endothelial cell interactions: therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Stepping out of the flow: capillary extravasation in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

The therapeutic promise of the cancer stem cell concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

CD44 and EpCAM: cancer-initiating cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Beyond tumorigenesis: cancer stem cells in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectins: a family of animal beta-galactoside-binding lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectins: structure, function and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Apoptosis of T cells mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Tumor cells secrete galectin-1 to enhance endothelial cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

The role of galectins in colorectal cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Cell surface glycan-lectin interactions in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9471-7

Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1

21 January 2018

1 reference

12 December 2020

Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion

1 reference

12 December 2020

Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate

1 reference

12 December 2020

Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell

1 reference

12 December 2020

10.1007/S10585-012-9471-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22484915%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference